Hypoxia and Mitochondrial Dysfunction in Pregnancy Complications

• Main Authors: Xiang-Qun Hu, Lubo Zhang
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Antioxidants
• Subjects: preeclampsia; fetal growth restriction; placenta; mitochondria; reactive oxygen species; oxidative stress
• Online Access: https://www.mdpi.com/2076-3921/10/3/405

Hypoxia is a common and severe stress to an organism’s homeostatic mechanisms, and hypoxia during gestation is associated with significantly increased incidence of maternal complications of preeclampsia, adversely impacting on the fetal development and subsequent risk for cardiovascular and metabolic disease. Human and animal studies have revealed a causative role of increased uterine vascular resistance and placental hypoxia in preeclampsia and fetal/intrauterine growth restriction (FGR/IUGR) associated with gestational hypoxia. Gestational hypoxia has a major effect on mitochondria of uteroplacental cells to overproduce reactive oxygen species (ROS), leading to oxidative stress. Excess mitochondrial ROS in turn cause uteroplacental dysfunction by damaging cellular macromolecules, which underlies the pathogenesis of preeclampsia and FGR. In this article, we review the current understanding of hypoxia-induced mitochondrial ROS and their role in placental dysfunction and the pathogenesis of pregnancy complications. In addition, therapeutic approaches selectively targeting mitochondrial ROS in the placental cells are discussed.